Oct 2, 2008 by Brian Orelli, PhDWill Lilly Buy ImClone's Troubles?Eli Lilly is reportedly ImClone's mystery suitor. Would it be a good deal?
Oct 2, 2008 by Brian Orelli, PhDWill Johnson & Johnson Ever Get Its Money?Boston Scientific and Medtronic owe the company money, but will they pay up?
Oct 1, 2008 by Brian Orelli, PhD3 Drugmakers With Multiple Shots on GoalWell-stocked pipelines could kick these drugmakers into super-high gear.
Oct 1, 2008 by Brian Orelli, PhDIs Pfizer the Mystery Bidder?A few signals that Pfizer might be the one bidding on ImClone.
Sep 30, 2008 by Brian Orelli, PhDThe Lethal Lessons of EprexThe FDA's concerned about J&J's blood-boosting drug. Should investors be, too?
Sep 30, 2008 by Brian Orelli, PhDCardinal Health Clips Its WingsDoes it make sense for the drug wholesaler to spin off its medical equipment business?
Sep 30, 2008 by Brian Orelli, PhDPharma, Cash, and YouPharma's been saving for a rainy day, and there's a thunderstorm outside.
Sep 29, 2008 by Brian Orelli, PhDAn Overnight 2-BaggerA nod from the FDA and a new partnership boost Indevus shares. Where to, now?
Sep 25, 2008 by Brian Orelli, PhDTeva Heads to JapanIt's conquering the world, slowly but surely. But is it still a value play?
Sep 25, 2008 by Brian Orelli, PhDMedicis Restates, Investors PanicMedicis says it'll have to restate earnings.
Sep 24, 2008 by Brian Orelli, PhDAriad's Lawsuit Loss and Investors' GambleAriad's patents don't cover Enbrel, but that's more of a side show.
Sep 24, 2008 by Brian Orelli, PhD100% Results From SequenomThe company presents more data on its molecular diagnostic and buys a lab to run the tests in.
Sep 24, 2008 by Brian Orelli, PhDHealth Insurer Lets Outsiders DecideAetna offers external reviews to customers it wants to boot.
Sep 24, 2008 by Brian Orelli, PhDHey, You! Stop!So what if your drug company was selling an unapproved drug?
Sep 23, 2008 by Brian Orelli, PhDExtended Look at an Extended-Release DrugThe FDA is still investigating Teva's generic Wellbutrin XL.
Sep 22, 2008 by Brian Orelli, PhDSyneron Irons Out Some WrinklesThe aesthetic device maker gets a new product approved in Europe.
Sep 22, 2008 by Brian Orelli, PhDinVentiv inTrouble? The pharma outsourcing company sees a huge one-day drop.
